awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55065136-8DFD7AFB-4B99-4BCF-8707-CEE7277021E2
Q55065136-8DFD7AFB-4B99-4BCF-8707-CEE7277021E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55065136-8DFD7AFB-4B99-4BCF-8707-CEE7277021E2
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab.
P2860
Q55065136-8DFD7AFB-4B99-4BCF-8707-CEE7277021E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55065136-8DFD7AFB-4B99-4BCF-8707-CEE7277021E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
646962e4628e568252b506b623b01112a9ad7bc7
P2860
HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.